Sunshine Nuohe announced that in order to advance the strategic layout, the company transferred 408.65 million yuan of registered capital of Biling Biotech held by Hangzhou Jiaozi Tea Industry for 10 million yuan. Before the transfer, the company held 2.0435% of Biling Biotech's shares, and will hold 2.2671% after the transfer. The investment has been reviewed by the General Manager's Office and does not constitute a related transaction or major asset restructuring. However, changes to the industrial and commercial registration still need to be approved, and the target company may face various risks in its operation. Investors are reminded to pay attention.

Sunshine Nuohe announced that in order to advance the strategic layout, the company transferred 408.65 million yuan of registered capital of Biling Biotech held by Hangzhou Jiaozi Tea Industry for 10 million yuan. Before the transfer, the company held 2.0435% of Biling Biotech's shares, and will hold 2.2671% after the transfer. The investment has been reviewed by the General Manager's Office and does not constitute a related transaction or major asset restructuring. However, changes to the industrial and commercial registration still need to be approved, and the target company may face various risks in its operation. Investors are reminded to pay attention.